SCHEMBL21532952

SCHEMBL21532952

Cc1ccc2cccc(C(=O)Nc3cccc(F)c3)c2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.55
RAB9A P51151 8/20 0.55
POLB P06746 2/20 0.55
GBA1 P04062 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
PARP1 P09874 1/20 0.52
HTT P42858 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
MAOB P27338 1/20 0.50
TSHR P16473 1/20 0.49
HPGD P15428 1/20 0.49
AR P10275 1/20 0.48
CBR1 P16152 1/20 0.48
AKR1C3 P42330 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19206635 0.85 MAPT (0.61) NPC1RAB9APOLBGBA1PARP1
SCHEMBL21532932 0.81 NPC1 (0.71) NPC1RAB9APOLBGBA1SMN1; SMN2
SCHEMBL19206634 0.81 NR1H4 (0.57) NPC1RAB9APARP1GAAMAPT
SCHEMBL19206639 0.80 PARP1 (0.56) NPC1RAB9ASMN1; SMN2PARP1GAA
SCHEMBL21532953 0.79 RAB9A (0.56) NPC1RAB9APOLBGBA1PARP1
SCHEMBL21532931 0.77 RAB9A (0.57) NPC1RAB9ASMN1; SMN2PARP1GAA
SCHEMBL19206631 0.77 PARP1 (0.59) NPC1RAB9APOLBPARP1GAA
SCHEMBL29620415 0.76 MAPT (0.61) NPC1RAB9AHTTMAPTKMT2A
SCHEMBL19206640 0.76 PARP1 (0.55) NPC1RAB9APOLBPARP1GAA
SCHEMBL19240119 0.75 PNLIP (0.54) NPC1RAB9ASMN1; SMN2PARP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10730839-B2 Quinolines as cytoprotective agents NEURODON CORPORATION 2020-08-04 US disclosed
US-20190330156-A1 QUINOLINES AS CYTOPROTECTIVE AGENTS NEURODON CORPORATION 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10730839-B2 Quinolines as cytoprotective agents IAPP, NFE2L2, NLN NPC1 316/4885RAB9A 1744/4885POLB 2190/4885
US-20190330156-A1 QUINOLINES AS CYTOPROTECTIVE AGENTS IAPP, NFE2L2, NLN NPC1 316/4885RAB9A 1744/4885POLB 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.